76 Chapter 5 [16] Umezawa R, Ota H, Takanami K, Ichinose A, Matsushita H, Saito H, et al. MRI findings of radiationinduced myocardial damage in patients with oesophageal cancer. Clin Radiol 2014;69:1273–9. https://doi.org/10.1016/j.crad.2014.08.010. [17] Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: A comprehensive review. J Cardiovasc Magn Reson 2016;18. https://doi.org/10.1186/s12968-016-0308-4. [18] Jellis CL, Kwon DH. Myocardial T1 mapping: modalities and clinical applications. Cardiovasc Diagn Ther 2014;4:126–12637. https://doi.org/10.3978/j.issn.2223-3652.2013.09.03. [19] Diao K yue, Yang Z gang, Xu H yan, Liu X, Zhang Q, Shi K, et al. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc Magn Reson 2016;18:1–11. https://doi.org/10.1186/s12968-016-0313-7. [20]Takagi H, Ota H, Umezawa R, Kimura T, Kadoya N, Higuchi S, et al. Left Ventricular T1 Mapping during Chemotherapy–Radiation Therapy: Serial Assessment of Participants with Esophageal Cancer. Radiology 2018;289:347–54. https://doi.org/10.1148/radiol.2018172076. [21] Feng M, Moran JM, Ph D, Koelling T, Chughtai A, Chan JL, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer 2012;79:10–8. https://doi.org/10.1016/j.ijrobp.2009.10.058.Development. [22]Lang RM, Badano LP, Mor-avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging 2015. https://doi.org/10.1093/ehjci/jev014. [23]Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi R, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol 2017;122:416–22. https://doi.org/10.1016/j.radonc.2017.01.008. [24]Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagin. J Cardiovasc Magn Reson 2017;19:1–24. https://doi.org/10.1186/s12968-017-0389-8. [25]Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A, et al. T1Mapping by cardiac magnetic resonance imaging: from histological validation to clinical implication. J Am Coll Cardiol 2016;67:1696. https://doi.org/10.1016/s0735-1097(16)31697-7. [26]Vita T, Gräni C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, et al. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. JACC Cardiovasc Imaging 2019;12:1659–69. https://doi.org/10.1016/j. jcmg.2018.08.021. [27]Zhuang B, Sirajuddin A, Wang S, Arai A, Zhao S, Lu M. Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis. Heart Fail Rev 2018;23:723–31. https://doi.org/10.1007/s10741-018-9718-8. [28]Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 2015;4:1–14. https://doi.org/10.1161/JAHA.115.002613. [29]Cai G, Li C, Yu J, Meng X. Heart Dosimetric Parameters Were Associated With Cardiac Events and Overall Survival for Patients With Locally Advanced Esophageal Cancer Receiving Definitive Radiotherapy. Front Oncol 2020;10:1–13. https://doi.org/10.3389/fonc.2020.00153. [30]Ghobadi G, van der Veen S, Bartelds B, de Boer R a, Dickinson MG, de Jong JR, et al. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 2012;84:e63946. https://doi.org/10.1016/j.ijrobp.2012.07.2362. [31] Gyenes G, Fornander T, Carlens P, Glas U R LE. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiot Oncol Biol Phys 1996;36:899–905.
RkJQdWJsaXNoZXIy MTk4NDMw